When do we report the JW modifier?
Effective January 1, 2017, providers and suppliers were required to report the JW modifier as a way to identify and be paid for unused drugs and biologicals. The basic guidelines for the modifier are: The JW modifier is applicable for claims with unused drugs or biologicals from single-use vials or single-use packages that are appropriately discarded (except for provided dosages that are under the CAP for Part B drugs and biologicals); The JW modifier is applied to the amount of drug or biological that is discarded, and it is billed on a separate line item; and The discarded drug/biological must be documented in the patient’s medical record.
This question was answered in our Coding Essentials for Infusion & Injection Therapy Services. For more hot topics relating to infusion services, please visit our store or call us at 1.800.252.1578, ext. 2.
CPT® copyright 2024 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Subscribe to receive our News, Insights, and Compliance Question of the Week delivered right to your inbox.
Address: 5874 Blackshire Path, #13, Inver Grove Heights, MN 55076
Phone: (800) 252-1578
Email: support@medlearnmedia.com
Hours: 9am – 5pm CT
Copyright © 2025 MedLearn Publishing. Powered by MedLearn Media.
Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →
Unlock 50% off all 2024 edition books when you order by July 5! Use the coupon code CO5024 at checkout to claim this offer!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24